ischemic heart disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients with stable or unstable angina pectoris or myocardial infarction aged >= 18 years; 2.Coronary angiography showed epicardial coronary artery diameter stenosis >= 50%; 3.Patients who underwent FFR, QFR, IVUS or ivusfr due to the diagnosis or treatment of coronary artery disease; 4.Be able to understand the purpose of this trial and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. Pregnant women 2. The expected survival time is less than 1 year 3. The target lesion was located in the bridging vessels 4. Creatinine > 150 umol/L or the glomerular filtration rate was less than 45 ml / kg / 1.73 m^2.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Major adverse cardiac events (MACE);Incidence of target vessel therapy failure (TVF);Incidence of any coronary revascularization; | — |
Countries
China
Contacts
Beijing Tiantan Hospital, Capital Medical University